MedPath
TGA Approval

PROHANCE gadoteridol 2793mg/10mL injection vial (263733)

263733

PROHANCE gadoteridol 2793mg/10mL injection vial

Bracco Pty Ltd

April 26, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/f542224ee3a9d06701a231068b326358.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/3803ab43fdcea007b8636c4a55ffed9f.pdf

Active Ingredients

gadoteridol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROHANCE gadoteridol 2793mg/10mL injection vial (263733) - TGA 批准文号 | MedPath